Validation of the VITEK2 and the advance expert system with a collection of enterobacteriaceae harboring extended spectrum or inhibitor resistant β-lactamases

This publication has 20 references indexed in Scilit:

• Variations in the Prevalence of Strains Expressing an Extended‐Spectrum β‐Lactamase Phenotype and Characterization of Isolates from Europe, the Americas, and the Western Pacific Region
  Clinical Infectious Diseases, 2001
• Controversies about Extended-Spectrum and AmpC Beta-Lactamases
  Emerging Infectious Diseases, 2001
• Nucleotide Sequence and Characterization of a Novel Cefotaxime-Hydrolyzing β-Lactamase (CTX-M-10) Isolated in Spain
  Antimicrobial Agents and Chemotherapy, 2001
• Laboratory detection of extended-spectrum β-lactamases (ESBLs)—The need for a reliable, reproducible method
  Diagnostic Microbiology and Infectious Disease, 2000
• CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes
  International Journal of Antimicrobial Agents, 2000
• Verification and validation of procedures in the clinical microbiology laboratory
  Clinical Microbiology Newsletter, 1997
• A functional classification scheme for beta-lactamases and its correlation with molecular structure
  Antimicrobial Agents and Chemotherapy, 1995
• New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak
  Antimicrobial Agents and Chemotherapy, 1995
• Origin and impact of plasmid-mediated extended-spectrum beta-lactamases
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
  Annals of Internal Medicine, 1993